Turn Therapeutics (TTRX) Profit After Tax (2024 - 2026)
Turn Therapeutics (TTRX) recorded quarterly Profit After Tax of -$970972.0 in Q1 2026, down 451.9% quarter-over-quarter from $275920.0 in Q4 2025, and down 195.54% on a YoY basis from $1.0 million in Q1 2025.
Turn Therapeutics (TTRX) Profit After Tax (2024 - 2026) Analysis & Trends
Turn Therapeutics' Profit After Tax history runs 3 years deep, the most recent figure standing at -$970972.0 for Q1 2026.
- In Q1 2026, Profit After Tax fell 195.54% year-over-year to -$970972.0; the TTM figure through Mar 2026 stood at -$2.9 million (changed N/A YoY), while the FY2025 annual figure was -$3.2 million, down 80.62% from the prior year.
- Profit After Tax was -$970972.0 for Q1 2026 at Turn Therapeutics, down from $275920.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $275920.0 in Q4 2025 to a low of -$1.9 million in Q3 2025.
- Historically, Profit After Tax has averaged -$652892.5 across 3 years, with a median of -$497494.5 in 2024.
- The sharpest annual moves came in 2025 and 2026: Profit After Tax jumped 185.39% in 2025, then tumbled 195.54% in 2026.
- A 3-year view of Profit After Tax shows it stood at -$323130.0 in 2024, then surged by 185.39% to $275920.0 in 2025, then sank by 451.9% to -$970972.0 in 2026.
- The last three Profit After Tax figures came in at -$970972.0 (Q1 2026), $275920.0 (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Turn Therapeutics | 175.38 Mn | 175.38 Mn | - | -970,972.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -970,972.00 |
| Dec 31, 2025 | 275,920.00 |
| Sep 30, 2025 | -1.90 Mn |
| Mar 31, 2025 | -328,547.00 |
| Dec 31, 2024 | -323,130.00 |
| Sep 30, 2024 | -666,442.00 |